Zollinger‑Ellison syndrome – metastatic gastrinoma - Symptoms, Causes, Treatment & Prevention

Diagnosis

Because symptoms overlap with common peptic ulcer disease, a high index of suspicion is essential.

Biochemical Testing

• Fasting Serum Gastrin Level: >1000 pg/mL (normal < 100 pg/mL) is highly suggestive, especially when gastric pH <2.^[3]
• Secretin Stimulation Test: Gastrin rises >120 pg/mL after IV secretin in ZES (paradoxical response).
• pH Monitoring (24‑hour gastric pH): Persistent acidity (<2) despite acid‑blocking therapy.

Imaging Studies

• Multiphasic Contrast‑Enhanced CT (Pancreas Protocol): Detects primary tumor and liver metastases.
• Magnetic Resonance Imaging (MRI) with MRCP: Superior for soft‑tissue contrast and hepatic lesions.
• 68Ga‑DOTATATE PET/CT: Gold standard for neuroendocrine tumor localization; identifies somatostatin‑receptor–positive disease.
• Endoscopic Ultrasound (EUS): High‑resolution view of pancreas and duodenum; enables fine‑needle aspiration for histology.

Pathology

If a lesion is biopsied, pathology shows neuroendocrine cells staining positive for gastrin, chromogranin A, and synaptophysin. Ki‑67 proliferative index helps grade the tumor (G1‑G3).

Treatment Options

Treatment is multimodal: control acid hypersecretion, eradicate or control tumor growth, and manage metastases.

Acid‑Suppressive Therapy (First‑Line)

• High‑Dose Proton Pump Inhibitors (PPIs): Omeprazole 40‑80 mg/day or equivalent; often required indefinitely.
• H2‑Receptor Antagonists: Used adjunctively when PPIs are insufficient.
• Goal: Maintain gastric pH > 4 to allow ulcer healing and improve quality of life.

Surgical Management

• Curative Resection: For localized gastrinoma (≤2 cm, no nodal disease) – enucleation or pancreaticoduodenectomy (Whipple). 5‑year disease‑free survival ≈ 70 % when complete resection achieved.^[4]
• Debulking Surgery: Reduces tumor burden in metastatic disease; may improve symptom control and eligibility for other therapies.

Systemic Therapies for Metastatic Gastrinoma

• Somatostatin Analogues (SSA): Octreotide or lanreotide inhibit gastrin release and may modestly slow tumor growth.
• Targeted Therapy: Everolimus (mTOR inhibitor) approved for progressive, well‑differentiated neuroendocrine tumors.
• Peptide‑Receptor Radionuclide Therapy (PRRT): 177Lu‑DOTATATE delivers radiation directly to somatostatin‑receptor–positive cells; improves progression‑free survival (median ~28 months).^[5]
• Chemotherapy: Reserved for high‑grade (G3) or rapidly progressive disease; regimens include streptozocin‑based combos or temozolomide‑capecitabine.

Locoregional Therapies for Liver Metastases

• Radiofrequency Ablation (RFA) or Microwave Ablation: For limited (<5 cm) lesions.
• Trans‑arterial Embolization (TAE) / Chemoembolization (TACE): Reduces tumor vascularity and symptom burden.
• Liver Resection: Considered when metastases are resectable and patient’s hepatic reserve is adequate.

Lifestyle & Supportive Measures

• Small, low‑fat meals to reduce acid stimulus.
• Avoid NSAIDs, aspirin, and alcohol, which aggravate ulcer disease.
• Calcium and vitamin D supplementation if malabsorption leads to deficiency.
• Psychosocial support and counseling—living with a rare chronic cancer can be stressful.

Living with Zollinger‑Ellison Syndrome – Metastatic Gastrinoma

Effective long‑term management hinges on a partnership between the patient, gastroenterologist, oncologist, and surgeon.

Medication Adherence

• Take PPIs exactly as prescribed; missing doses can cause rebound hyperacidity.
• Set reminders for monthly SSA injections.

Nutrition

• Eat 5–6 small meals per day; include complex carbohydrates and lean protein.
• Limit citrus, tomato‑based foods, caffeine, and spicy foods that trigger acid secretion.
• Consider a dietitian referral for individualized plans, especially if steatorrhea leads to calorie loss.

Monitoring & Follow‑Up

• Serum gastrin and chromogranin A levels every 3–6 months.
• Imaging (CT or MRI) every 6–12 months to track metastatic lesions.
• Endoscopy every 1–2 years or sooner if new ulcer symptoms appear.

Physical Activity

• Gentle aerobic exercise (walking, swimming) 150 minutes per week helps maintain weight and mood.
• Avoid high‑impact activities if you have severe abdominal pain or recent ulcer bleeding.

Emotional & Practical Support

• Join rare‑disease or neuroendocrine tumor support groups (e.g., NET Patient Foundation).
• Keep a symptom diary to share with your care team.
• Discuss advance directives and insurance coverage early, as treatment may be prolonged.

Prevention

Because most gastrinomas are sporadic, primary prevention is limited. However, the following steps can reduce overall risk or aid early detection:

• Genetic Counseling: If you have a family member with MEN‑1, undergo testing; early surveillance can catch tumors before metastasis.
• Avoid Chronic Gastric Irritation: Minimize long‑term NSAID or heavy alcohol use.
• Routine Screening for High‑Risk Individuals: Annual fasting gastrin level and abdominal imaging for MEN‑1 carriers starting in adolescence.

Complications

If untreated or inadequately controlled, ZES can lead to serious health problems:

• Recurrent or Perforated Ulcers: May cause peritonitis, sepsis, and require emergency surgery.
• Gastrointestinal Bleeding: Chronic blood loss → anemia, fatigue, and need for transfusions.
• Malabsorption & Nutritional Deficiencies: Fat‑soluble vitamins (A, D, E, K) and iron deficiency.
• Peptic Ulcer Disease–Related Strictures: Can cause obstructive symptoms.
• Metastatic Progression: Liver failure, biliary obstruction, or portal hypertension.
• Electrolyte Imbalance: Chronic diarrhea → hypokalemia, metabolic alkalosis.
• MEN‑1 Associated Tumors: Hyperparathyroidism leading to hypercalcemia, pituitary adenomas causing visual disturbances.

When to Seek Emergency Care

If you experience any of the following, call 911 or go to the nearest emergency department immediately:

• Severe abdominal pain with a rigid or board‑like abdomen (possible perforated ulcer).
• Vomiting bright red blood or material that looks like coffee grounds.
• Black, tarry stools (melena) indicating significant gastrointestinal bleeding.
• Sudden, profuse diarrhea leading to dizziness, rapid heartbeat, or fainting.
• High fever (>101 °F / 38.3 °C) with worsening abdominal pain (possible infection or sepsis).
• Jaundice (yellowing of skin/eyes) accompanied by abdominal swelling—may signal liver metastasis complications.

Early medical attention can be life‑saving and prevent irreversible organ damage.

Sources:

1. Mayo Clinic – Zollinger‑Ellison Syndrome
2. NIH – MEN‑1 and Gastrinomas
3. CDC – Pancreatic Neuroendocrine Tumors
4. Cleveland Clinic – ZES Overview
5. Strosberg et al., NEJM 2017 – PRRT in NETs